Tehran University of Medical Sciences

Science Communicator Platform

Share By
Challenges and Future Strategies for Management of Otomycosis Caused by Fusarium Species: A Systematic Review and Meta-Analysis Publisher



Haghani I ; Rizi ZT ; Kermani F ; Javidnia J ; Ghazanfari M ; Roohi B ; Ghafari M ; Hedayati MT ; Khojasteh S ; Shokoohi G ; Nosratabadi M ; Abastabar M ; Otasevic S ; Farokhi Z Show All Authors
Authors
  1. Haghani I
  2. Rizi ZT
  3. Kermani F
  4. Javidnia J
  5. Ghazanfari M
  6. Roohi B
  7. Ghafari M
  8. Hedayati MT
  9. Khojasteh S
  10. Shokoohi G
  11. Nosratabadi M
  12. Abastabar M
  13. Otasevic S
  14. Farokhi Z
  15. Badali H
  16. Alhatmi AMS

Source: Current Medical Mycology Published:2025


Abstract

Background and Purpose: Otomycosis caused by Fusarium species has been increasingly documented in recent years. This study aimed at an overview of clinical presentations, diagnostic methods, treatment alternatives, epidemiology, and future management strategies for this infection. Materials and Methods: A literature search was conducted in five scientific databases from 1966 to July 2023. The keywords included Fusarium, fusariosis, otomycosis, otitis externa, ear disorder, and ear infection. After title and abstract screening, 354 papers advanced to full-text screening; subsequently, 343 were excluded as non-relevant or case reports, leaving 11 studies to be included in this review. Results: Fusarium otomycosis primarily occurs in healthy individuals, particularly those with diabetes or a history of trauma or ear infections. Clinical symptoms include pruritus, pain, otorrhea, hearing loss, and external ear canal inflammation. Diagnosis mainly uses conventional methods, though molecular techniques offer accurate species identification. Treatment is challenging due to resistance to traditional antifungals; however, topical agents, like terbinafine, voriconazole, amphotericin B, and natamycin, show promise in management. In this review, the pooled prevalence of otomycosis due to Fusarium species is estimated at 2.3 (95% CI= 1.2-3.7). Conclusion: The findings indicated that otomycosis caused by Fusarium species is an emerging clinical entity that warrants attention. Considering the resistance of Fusarium species to most currently available antifungal drug classes, physician awareness and proper diagnostic techniques are essential for timely diagnosis, accurate identification, and appropriate management of this infection. © 2025 Mazandaran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Isolation, Characterization, and Antifungal Sensitivity Pattern of Fungal Species With Potential Resistance to Antifungal Drugs in Patients With Otomycosis, Archives of Clinical Infectious Diseases (2022)
2. Otomycosis: A Systematic Review and Meta-Analysis of Prevalence and Causative Agents in the Era of Molecular Diagnostics, BMC Infectious Diseases (2025)
3. Investigation of Etiologic Agents and Clinical Presentations of Otomycosis at a Tertiary Referral Center in Tehran, Iran, Iranian Journal of Public Health (2019)
Experts (# of related papers)
View all Related Experts
Sadegh Khodavaisy (5)
Roshanak Daei Ghazvini (4)
Other Related Docs
4. Otomycosis Due to the Rare Fungi Talaromyces Purpurogenus, Naganishia Albida and Filobasidium Magnum, Mycopathologia (2020)
5. Isolation, Characterization, and Antifungal Sensitivity Pattern of Candida Species Causing Otomycosis, Acta Medica Iranica (2023)
6. Molecular Epidemiology of Otomycosis in Isfahan Revealed a Large Diversity in Causative Agents, Journal of Medical Microbiology (2019)
7. Otomycosis in Western Iran: Clinical and Mycological Aspects, Archives of Clinical Infectious Diseases (2017)
8. In Vitro Antifungal Susceptibility Profile of Iranian Fusarium Isolates: Emphasising on the Potent Inhibitory Effect of Efinaconazole Compared to Other Drugs, Mycoses (2023)
9. Invasive Fusarium Rhinosinusitis in Covid-19 Patients: Report of Three Cases With Successful Management, Frontiers in Cellular and Infection Microbiology (2023)
10. In Vitro Antifungal Susceptibility Testing of Clinical and Environmental Fusarium Isolates in Iran, Archives of Clinical Infectious Diseases (2018)
11. Isolation and Identification of Fusarium Species From the Water Systems of Icus and Transplant Wards of Hospitals and Determination of the in Vitro Susceptibilities of Isolates to Conventional Antifungals, Frontiers in Fungal Biology (2025)
12. Phylogenetic Relationship of Fusarium Species Isolated From Keratitis Using Tef1 and Rpb2 Gene Sequences, Iranian Journal of Microbiology (2022)
13. Candida Auris Colonization or Infection in the Ear of Four Patients With Chronic Otitis Externa: A Case Series and Literature Review, Current Medical Mycology (2026)
14. Black Aspergilli As Causes of Otomycosis in the Era of Molecular Diagnostics, a Mini-Review, Journal of Medical Mycology (2022)
15. Screening Candida Auris Through a Multiplex Stepwise Pcr Algorithm Directly From Clinical Samples of Patients Suspected of Otomycosis in South of Iran; Detection of Five Cases, Mycoses (2024)
16. Species Identification and in Vitro Antifungal Susceptibility Testing of Aspergillus Section Nigri Strains Isolated From Otomycosis Patients, Journal de Mycologie Medicale (2018)
17. A Mycological and Molecular Epidemiologic Study on Onychomycosis and Determination in Vitro Susceptibilities of Isolated Fungal Strains to Conventional and New Antifungals, Frontiers in Cellular and Infection Microbiology (2021)
18. Meningoencephalitis Caused by Fusarium Proliferatum: An Unusual Case, Infection (2022)